Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes Mellitus | Zendy

Gregg W. Stone | Zendy; Elvin Kedhi | Zendy; Dean J. Kereiakes | Zendy; Helen Parise | Zendy; Martin Fahy | Zendy; Patrick W. Serruys | Zendy; Pieter C. Smits | Zendy

Open Access

Differential Clinical Responses to Everolimus-Eluting and Paclitaxel-Eluting Coronary Stents in Patients With and Without Diabetes Mellitus

Author(s) -

Gregg W. Stone,

Elvin Kedhi,

Dean J. Kereiakes,

Helen Parise,

Martin Fahy,

Patrick W. Serruys,

Pieter C. Smits

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.031070

Subject(s) - medicine , everolimus , percutaneous coronary intervention , stent , cardiology , diabetes mellitus , myocardial infarction , target lesion , coronary artery disease , revascularization , sirolimus , surgery , endocrinology

Some (but not all) prior trials have reported differential outcomes after percutaneous coronary intervention with paclitaxel-eluting stents versus stents eluting rapamycin analogs according to the presence of diabetes mellitus. These studies lacked sufficient power to examine individual safety and efficacy end points.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research